GVK Biosciences, a Hyderabad-based drug discovery research and development organisation, has extended the licence of its GVK Bio SAR databases (Gostar) to Tokyo-headquartered pharmaceutical company Astellas Pharma.
Gostar (GVK Bio Online Structure Activity Relationship) is an online scientific database product of GVK, which integrates information on compounds from discovery and development stages and marketed drugs.
The information provided includes SAR, ADME (absorption, distribution, metabolism and excretion), toxicity, preclinical, clinical and structural data for over 5.1 million compounds and 16.7 million SAR points.
“The Gostar database is becoming an indispensable tool for scientists in drug discovery. Several publications that have used the Gostar data validate the utility of this product,” Sreeni Devidas, vice-president (sales and marketing, informatics) at GVK Bio, stated in a press release on Monday.
